This phenomenon may be relevant to the optimal targeting of the glucagon-like peptide-1 receptor (GLP-1R), a type 2 diabetes and obesity target GPCR for which several ligands with varying internalisation tendency have been discovered. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.